We investigated the expression, distribution, and inducibility of 3-methylcholanthrene (MC)-inducible P450 enzymes, CYPlAl and 1A2, in livers of rabbits at different stages of development, ranging from 4 days before birth (-4 days of age) to adulthood. These enzymes were identified by immunoblotting and immunocytochemistry and quantified by dot-blotting, utilizing previously characterized monoclonal antibodies, 107 and 31412, specific for CYPIA2 and both CYPlAl and 1A2, respectively, and a polydonal antibody that recognizes both enzymes. Expression of CYPIA2 is always greater than that of CYPlAl in livers of untreated rabbits, regardless of age. Moreover, immunocytochemistry showed that CYPlAl is evenly distributed throughout the liver at all ages, whereas CYPIA2 is highly localized to only a few scattered cells at 1 day before birth. More hepatocytes express this enzyme perinatally. By 6 days of age, expression of CYPIA2 is confined to a narrow band of centrilobular ceb, but with increasing age the enzyme is expressed in more hepatocytes until weaning, when all hepatocytes are posi-
Introduction
The hepatic, P450-dependent. mixed-function oxidase system is responsible for the metabolic activation of many compounds in the fetus of mammalian species, including human (1). This may have important implications for the toxicity and carcinogenicity of drugs and other foreign compounds to the fetus. Cytochrome P450 comprises a superfamily of enzymes, the members of which exhibit unique but overlapping substrate specificities. In studies to date, there has been only a limited characterization of the specific P450 Supported tive. Although CYPlAl is induced by MC treatment at most ages, there is no change in its distribution. In contrast, induction of CYPIA2 was shown immunocytochemically to o c m in only a limited number of hepatocytes in fetal rabbits. There is a progressive increase with age in the number of hepatocytes that are inducible for CYPlA2. The greatest fold-induction of hepatic CYPlA2 by MC in the rabbit is a 9-11 days of age, when, for MC-treated rabbits, CYPIA2 represents X O % of the total P450 pool. The modulation of enzyme expression caused by MC treatment of fetuseslneonates leads to developmentally advanced livers with respect to P450 and could have a significant impact on the fetal and neonatal toxicity of some foreign compounds. These data demonstrate, for the first time, that the ontogenetic expression and localization of CYPlAl and 1A2 within the liver are differentially regulated at the level of the individual cell. ( J Histochem Cyrdem 41:915-925, 1993) KEY WORDS: Ontogeny of CYPIA; Liver; Monoclonal antibodies; Immunocytochemical studies; Rabbit. phenotype expressed in tissues of the fetus and neonate. Interestingly, in those studies that have been reported, hepatic monooxygenase activities have shown distinct ontogenetic patterns, suggesting that the P450 enzymes are expressed at different phases of development, as has been shown for the UDP-glucuronosyl transferases (2) . Although rodent embryos are clearly able to metabolize a limited number of xenobiotics (3-6), it is not until the principal organs, such as the liver, lung, kidneys, and intestine, reach maturity a few days before parturition that relatively high metabolic capacity begins to develop. Indeed, only after birth do marked increases in benzo[a]pyrene hydroxylase, 7-ethoxyresorufin 0-deethylase, biphenyl-4-hydroxylase, acetanilide 4-hydroxylase, and N-acetylarylamine N-hydroxylase activities occur (7-10). The development of highly specific monoclonal and polyclonal antibodies and RNA hybridization probes, recognizing either subfamilies or even single P450 enzymes (particularly of the CYPIA, CYP2B, CYPZC, and CYP3A subfamilies), has led to their unequivocal identification in embryonic, perinatal, and neonatal tissue (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . However, the overlapping substrate specificity exhibited by the P450 enzymes has prevented accurate determination of the contribution of any single constitutive enzyme in a given activity in some of these studies (9JOJ5).
In contrast to the situation in untreated animals, changes in the inducibility of some P450 enzymes, particularly, and of interest here, CYPlAl and 1A2, have been shown to correlate with changes in the inducibility of certain monooxygenase activities, notably benzo[ alpyrene hydroxylase activity and the N-hydroxylation of aromatic amines (9,20-24). Thus, based on changes in these enzyme activities, critical stages during development have been identified for the inducibility of CYPlAl and 1A2. For example, although CYPIA1 and 1A2 are both inducible in livers of adult rabbits (25) , it has been reported that only CYPlAl is increased in fetal livers after polycyclic aromatic hydrocarbon treatment (7,26). Not until rabbits reach their neonatal stage of development (i.e., 1-2 weeks after parturition) does CYPIA2 become responsive to such inducers, thus demonstrating the temporal regulation of induction of these enzymes (7).
We and others, using immunocytochemical techniques, have previously reported that these and other P450 enzymes exhibit a zonal distribution in adult liver (27) (28) (29) . This is thought to be an important factor in explaining the pattern of liver damage caused by some drugs and toxic chemicals. The effect of age on the relative distribution of different P450 enzymes, not only between tissues but also within tissues, which are more often than not composed of heterogeneous cell populations, has yet to be determined. The use of immunochemical techniques has been extended for the first time in these studies to investigate the developmental expression and patterns of distribution of CYPlAl and 1A2 in liver from untreated and 3-methylcholanthrene (MC)-treated rabbit with the highly specific monoclonal antibodies (MAb) 107 (30) and 3/4/2 (31).
Materials and Methods
Chemicals and Reagents. Dichlorodifluoromethane (Arcton), synthetic mounting medium containing resin in xylene (Pertex), Tissue-Tek I1 embedding medium, hydrogen peroxide, counterstains. and acetone were obtained from Merck (Dorset, UK); sodium pentobarbital (60 m g / d and 200 mg/ml) was from RhBne-Poulenc (Manchester, UK). Most of the reagents used for sodium dcdecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were obtained from National Diagnostics (Buckinghamshire, UK) and nitrocellulose membrane was purchased from Amersham (Buckinghamshire, UK). Rabbit anti-mouse and goat anti-rabbit IgG conjugated to horseradish peroxidase were obtained from ICN Flow (Buckinghamshire. UK). All other reagents were supplied by Sigma (Dorset, UK).
Treatment of Animals. Sexually mature male and female New Zealand White rabbits (3-4 kg) and weanling rabbits (1.8-2.2 kg) (Interfauna UK; Cambridge, UK) were housed singly in steel, grid-bottomed cages, and 6-8day-old (120-190 g) and 14-18-day-old (180-270 g) New Zealand White male rabbits (Froxfield Farms; Hampshire. UK) were housed in groups of three to six animals per cage. Sexually matbre female rabbits were each primed with an injection of 25 IU chorionic gonadotropin and 21 days later were artifkially inseminated. Pregnant rabbits were housed singly with nesting facilities and dams with their litters. All animals were subject to a controlled 12-hr light and 12-hr dark lighting regimen and had free access to food (R14B diet) (Labsure Animal Products; Dorset, UK) and water. Non-pregnant adult female, adult male, neonatal (4-, 8-, and 16-day-old) male and female weanling rabbits either were not treated or received a single IP injection of MC in corn oil, 100 mglkg body weight, 48 hr before sacrifice. Groups of pregnant rabbits either were not treated or received similar doses on a per kg body weight basis on days 25/26 (-4 day old, fetalweights 15-25 g), 27/28 (-1 day old, fetal weights 36-53 g), or 29/30 (1-day-old newborn, weights 48-70 g) of gestation. Fetuseslnewborns were sacrificed 48 hr later, after cesarean section if necessary.
Monodonal Antibodies. The production, purification, and characterization of the specificity of the antibodies used in this study (MAb 107 and 3/4/2) have been described previously (30, 31) . These antibodies were derived from the fusion of the mouse myeloma cell line P3.NSl.l-Ag4-1 (NS1 cells) with splenic lymphocytes obtained from Balblc mice immunized with preparations of either CYPlAl or 1A2, partially purified from the livers of MC-treated rats or rabbits, respectively. MAb 107 was prepared in quantity by inoculation of mice with actively growing hybridoma cells and was purified by ammonium sulfate precipitation and ion exchange chromatography using a Q-Sepharose Fast Flow column (Pharmacia; Milton Keynes, UK) according to the method ofEdwards et al. (32) . The antibody was eluted by increasing the concentration of NaCl from 70 mM to 100 mM, and fractions containing MAb 107 were pooled and dialyzed against phosphate-buffered saline (PBS 140 mM NaCI, 3 mM KCI, 8 mM Na2HP04 and 1.5 mM KH2P04), pH 7.4. Residual albumin was removed by Affi-Gel Blue chromatography. MAb 3/4/2 was grown in bulk culture by Celltech (Slough, UK) and IgG was harvested from the tissue supernatant by polyethylene glycol precipitation.
Tissue Preparation. Animals were sacrificed by an overdose of sodium pentobarbital administered either via a marginal ear vein in weanlings and adults or IP in neonates. Fetuses were sacrificed by decapitation. Livers (pooled fetal and newborn groups) were removed, chopped into pieces, and frozen in liquid nitrogen. Tissue for cryostatic sectioning was prepared as described by Rich et al. (29) . Microsomal fractions were prepared from the remainder of the frozen livers by differential ultracentrifugation as described previously (7). Microsomal fractions were suspended in 0.25 M potassium phosphate buffet, pH 7.25, containing 30% (v/v) glycerol, to a protein concentration of >15 mglml, and stored at -8O'C until required. Protein concentration was determined by the method of Lowry et al. (33) by reference to a standard curve prepared using bovine serum albumin, fraction V (BSA, 50-350 pglml). The microsomal content of cytochrome P450 enzymes was determined spectroscopically according to Omura and Sat0 (34) , assuming an extinction coefficient of 91 mM-'.cm-' between 450-490 nm or according to Johannesen and DePierre (35) for microsomes prepared from fetal livers, assuming an extinction coefficient of 105 mM-*.cm-'.
Gel Electrophoresis, Immunoblotting, and Dot-blotting. Microsomal proteins were separated by SDS-PAGE with 9% polyacrylamide and electrophoretically transferred to 0.45-pm nitrocellulose membranes as described by Boobis et al. (31) . Dot-blotting was performed with a Bio-Dot microfiltration apparatus from Bio-Rad Laboratories (Hemel Hempstead, UK). Homogeneous rabbit CYPlA2 purified from MC-treated rabbit liver microsomes (previously prepared by B. Murray of this laboratory) was used to generate a standard curve from which levels of this enzyme in hepatic microsomal samples could be determined. Protein samples were diluted appropriately in PBS and added directly to the nitrocellulose membrane through the wells by applying suction with a vacuum pump. Nitrocellulose sheets containing transferred electrophoresed protein (immunoblots) or dotblots were immunostained as described previously (29) .
Specific antibody-antigen interaction after incubation of membranes with primary antibody followed by rabbit anti-mouse or goat anti-rabbit IgG, as appropriate, conjugated to horseradish peroxidase was detected by exposure for 15 min to 1 mM 4-chloro-1-naphthol in PBS containing 0.01% hydrogen peroxide. Immunoquantifhtion of CYPlA2 was achieved by computerized integration ofthe peaks obtained by scanning of dot-blots probed with MAb 107, using an Ultrascan XL enhanced laser densitometer (Pharmacia LKB Biotechnology; Buckinghamshire, UK). There was a linear relationship between the amount of protein applied to the nitrocellulose sheets and the density of the dot for rabbit CYPlA2 (15-500 fmollwell) and all of the microsomal preparations studied over the range of concentrations used in the present investigation (rX.95). The gradient ofthe concenuationdensity lines did not change after treatment of rabbits with MC.
Immunocytochemistry. Immunochemical localization of P450 was achieved as described previously (29) . Tissue sections from at least two age groups (fetallperinatal cf. neonatal/weanling) were assessed for their immunoreactivity towards all antibodies in any one experiment. Each age group was examined at least twice using a different combination of ages. Tissue sections were fixed in cold acetone for 15-20 min and then rehydrated in PBS, pH 7.4. Nonspecific binding sites were blocked by incubation in PBS containing 3% (wlv) BSA for a minimum of 10 min. Sections were then exposed to various dilutions (1:10-1:50,000) of MAb 107 or 3/4/2 (stock protein = 1 mglml) overnight at 4°C in a humidified chamber. After several washes in PBS, sections were exposed to rabbit anti-mouse IgG for 90 min at room temperature. Specific antibody-antigen complexes were visualized by development for 20 min in 0.025% 3,3'-diaminobenzidine teuahydrochloride in PBS containing 0.03% hydrogen peroxide. Sections were counterstained with Cole's hematoxylin, dehydrated, and mounted in Pertex. Negative controls were performed with B3A3, an MAb raised against bovine growth hormone, which does not recognize any known form of P450, or with diluent, either alone or with normal rabbit serum.
Hematoxylin and eosin staining of sections of liver from rabbits at most ages revealed that the hepatocytes had a "foamy" appearance, particularly in untreated animals. This was due to a high content of glycogen and fat in these cells (36) , which varied with the diet and age of the animal. During acetone fixation, these components were removed from the cytoplasm.
Sections were examined with a Reichart-Jung Polyvar light microscope (Cambridge Optical; Cambridge, UK) fitted with a Konica FT-1 SLR camera, using equivalent exposure for all sections. Photographs were taken with Kodak Technical 2415 film at an ASA setting of 100 and the film was developed in Kodak HCllO developer, diluted 1:100, for 8.5 min at 20°C. The inducibility of P450 in each tissue examined was assessed semiquantitatively from the titer of the MAb that produced a given staining intensity, i.e., induction of P450 in a tissue results in binding of the MAb at lower concentrations (higher dilutions) than in tissues of untreated animals. A minimum of five sections for each animal at each antibody dilution was examined, there being at least three animals per group. At no time were interindividual differences in staining within a group greater than those seen between groups.
Results

Total Microsomal P4SO Content
Total P4.50 content was less than 70 pmollmg protein in hepatic microsomal fractions of untreated -4-day-old rabbit fetuses, representing 10% or less of that in microsomal samples from adult livers ( Table 1) . Levels increased with age to a plateau of approximately 600 pmollmg protein in weanling and adult rabbits. MC treatment of rabbits caused significant increases in total P450 content at most ages, except perinatally (1 day of age). Maximum induction occurred in 9-11-day-old rabbits, in which levels were fourfold greater than those of untreated rabbits, although three-to (13) a CYPlA2 content of microsomal fractions of rabbit liver was immunoquantified by dot-blotting as described in Materials and Methods. Results are mean i SD from at least three separate microsomal preparations, with the number of determinations i n parentheses, with the exception of * which are the mean of two preparations only. In rabbits 6 days of age and older, levels of CYF'lA2 after MC treatment are signifcantly different from control values at p<O.Ool. The limit of detecrion of CYPlAZ was 2 pmol P450lmg protein.
fourfold induction was observed at -4 days of age (%able 1). These observations are in good agreement with previously published data (7,191.
Staining of Immunoblots of Liver Microsomes
Immunoblots of liver microsomal proteins from untreated and MCtreated rabbits were probed with a rabbit polyclonal antibody raised against a purified preparation of rat CYPlA2 (a kind gift of Dr. J. Hardwick, North East Ohio College of Medicine, Argonne, OH), which recognizes both CYPlAl and 1A2 in the rabbit. At the very high microsomal protein levels used to maximize the prospects of detecting low levels of these enzymes in hepatic microsomal samples, some additional high and low molecular weight bands were stained. However, these same bands were detected in immunoblots probed with only the second antibody (data not shown). Thus, they represent nonspecific staining by this antibody and do not reflect any lack of specificity of the first antibody.
No CYPlAl or 1A2 could be detected in immunoblots of microsomal samples from untreated fetal or newbom rabbits (Figure 1) . A band corresponding to CYPIA2, based on its co-migration with purified rabbit CYPlA2 (Mr 54,000) was detected in all livers from rabbits 6 days old and above, the intensity of which increased with age. A weak band (approximate Mr 57,000) corresponding to CYP1A1, based on its electrophoretic mobility, was detected in livers from 6-day-old, weanling, and adult rabbits (Figure 1 ). CYPIA2 in liver remained below the limits of detection by immunoblotting after MC treatment in rabbits 1 day old and younger. In contrast, CYPlAl was induced in livers from -4-day-old fetuses as revealed by the presence of an immunoreactive band that comigrated with that (MI 57,000) seen in adults (Figure l) . The intensity of this band in MC-treated animals decreased with increasing gestational age, being barely detectable in livers from -1-day-old fetuses. In livers from rabbits 6 days old and above, there was a marked increase in both CYPlAl and 1A2, the inducibility of which increased as a function of age (Figure 1 ).
Immunoquantzj5cation of CYPIA2 in Liver Microsomes
CYPlA2 could not be detected by dot-blotting in microsomal fractions from either untreated or MC-treated fetuses ( Table 1) . Very low levels (approximately 1% of adult values) were observed in livers within 24 hr after parturition. Thereafter, levels of CYPIA2 in-creased progressively, such that livers from 17-21-day-old and weanling rabbits contained approximately 40% of the level seen in adult livers. This enzyme was not inducible by MC treatment in rabbits 1 day after parturition, but at 6 days after parturition CYPIA2 content was induced about 20-fold, to approximately 15% of the total P450 content ( Table 1 ). The most dramatic induction of this enzyme occurred in 9-ll-day-old rabbits, in which levels rose from 9 pmollmg protein to 721 pmol/mg protein (>80-fold induction), representing about 60% of the total P450 content. Thereafter, in livers from weanling and adult rabbits, the fold-induction was not as great (four-to eightfold) and the contribution of CYPlA2 to total P450 was less (Table 1) . . ' , e
Effect of Age on the Hepatic Distribution of CYPlA2
Immunostaining with MAb 107. even at dilutions of 1:10, confirmed that CYPlA2 could not be detected in the liver 96 hr before birth (Figure 2a ; Table 2 ). However, in livers of -1-and 1-day-old rabbits, a few hepatocytes discributed around major vessels were intensely stained for this enzyme ( Table 2 ). The intensity of the immunoreaction varied among these cells but most hepatocytes were negative. By 6 days of age this enzyme was expressed only in a narrow band of centrilobular cells (one or two cell rows) (Figure 3a ). Strongly reacting hepatocytes were interspersed with moderate to weakly stained cells. The intensity and distribution of this immunoreaction did not change, even at high titers of antibody (Table  2) . No staining of other hepatocytes across the lobule was apparent. The distribution of CYPlA2 was similar in livers from 9-11and 17-21-day-old rabbits (Figure 4a ), although the enzyme was expressed in progressively more centrilobular hepatocytes with increasing age. In 17-21-day-old rabbits, staining of some periportal hepatocytes was evident. The intensity of the immunoreaction varied among individual cells. as in 6-day-old rabbits. In sectionsfrom weanling livers exposed to MAb 107, a strong specific immunoreaction was seen in all hepatocytes throughout the lobule, even at antibody dilutions of 1:10,000 (Table 2 ). In sections from some livers the immunoreaction was slightly more intense in centrilobular areas than around portal tracts. After MC treatment of dams, specific immunostaining of CYPIA2 in -4-day-old fetuses was evident in a few cells, indicating that this enzyme had been induced (Figure 2d ). In liver sections from 24-hr pre-and postpartum rabbits, increasing numbers of hepatocytes were stained specifically with MAb 107 after MC treatment of the dams (data not shown). However, in sections from 6-day-old rabbits, the number of cells staining specifically for CYPlA2 increased dramatically (Figure 3d ). All centrilobular cells were evenly stained, whereas hepatocytes of the midzonal and periportal areas varied in their intensity of immunostaining, some staining strongly and others weakly. In sections from MC-treated rabbits 9-11 days of age and older, all of the hepatocytes throughout the lobule were specifically and evenly immunostained ( Table 2 ), although the intensity of the immunoreaction was somewhat weaker than that in the most strongly stained hepatocytes of 6-day-old animals. There also appeared to be a downregulation in the content of CYPlA2 in some centrilobular cells, which were very intensely stained for this enzyme in untreated animals. However, immunotitration indicated that the enzyme had been induced throughout the majority of hepatocytes ( Table 2) . The degree of induction was greatest in those cells that were constitutively deficient in CYP1A2, i.e., periportal and midzonal cells.
Effect of Age on the Hepatic Distribution of CYPlAl
From the results of the dot-and immunoblotting studies, immunostaining with 31412 largely reflects the distribution of CYPlAl in the liver of untreated rabbits up to 9-11 days of age and thereafter of both CYPlAl and 1A2. After MC treatment of rabbits, localization of 3 / 4 2 immunostaining largely reflects that of CYPlAl alone only in perinatal rabbits. It was shown previously that 3/4/2 binds with equal affinity to CYPlAl and 1A2 in the rabbit (37) . Therefore, in all preparations the difference in staining by 31412 and 107 should accurately reflect the expression of CYPlAl.
Moderate to strong immunostaining of all hepatocytes throughout the lobule was observed on exposure of sections from -4-dayold rabbits to MAb 3/4/2 at dilutions of less than 1:lOO ( Figure  2c ; Table 2 ). The intensity of immunostaining with 31412 did not change with age, there being a consistently moderate immunoreaction at dilutions less than 1:lOO in most cells throughout the lobule, through to adulthood (Figure 3c ; Table 2 ). However, in some sections from perinatal and neonatal animals incubated with higher dilutions of antibody, stronger staining became more apparent in certain cells that were also positive for CYP1A2, as illustrated in Figure 3c . The distribution of 3 / 4 2 immunostaining did not change after MC treatment of rabbits 6 days old and younger (Figures 2f   and 3f ), nor was there any change in the distribution of staining in older animals (data not shown). Immunotitration of MAb 31412 indicated that livers from fetal and neonatal rabbits appeared to be poorly responsive to MC treatment, with little increase in the intensity of staining evident in livers at lower dilutions of the antibody until rabbits were at least 6 days of age (Table 2) .
When MAb 107 or 3/4/2 was replaced with an alternative monoclonal antibody not recognizing P450, i.e., MAb B3A3 raised against bovine growth hormone, at the same protein concentrations, there was a complete absence of staining of hepatocytes at all ages ( Figures  2b, 2e, 3b, 3e, 4b, and 4d ). However, there was significant staining of biliary epithelial cells of portal tracts when this antibody was used at low dilution (Figures 2b, 4b, and 4d ). Nonspecific staining was apparent in resident macrophages owing to high endogenous levels of peroxidase (38) .
Discussion
Evidence for differential regulation of the expression and inducibility of members of the CYPlA subfamily during development in the rabbit has accumulated over the past 15 years, since the first demonstration of changes in the respective protein bands on polyacrylamide gels. Levels of CYPlA have now been assessed by immunoblotting, dot-blotting, and immunocytochemistry. three techniques with different levels of sensitivity and resolution. The antibody used to detect CYPlAl immunocytochemically, 31412, recognizes both CYPlAl and 1A2 in the rabbit with approximately the same affinity (39) . Therefore, the staining observed with this antibody represents both enzymes. In contrast, MAb 107 is highly specific to CYP1A2, and hence the difference in staining between these two antibodies represents that due to CYP1A1.
The developmental profile and cellular expression of CYPlAl and 1A2 differ markedly. Although neither CYPlAl nor CYPIA2 can be detected in untreated rabbits before birth by immunoblotting techniques, the increased sensitivity and the ability of immunocytochemistry to detect expression in individual cells revealed the presence of both P450 enzymes in the liver before parturition. CYPlAl was detectable with MAb 3/4/2 from the earliest age studied, -4 days, to adulthood, being expressed in all hepatocytes of livers from untreated animals. Close inspection of the sections revealed more intense staining in some cells around the central vein, especially in liver sections of neonatal rabbits, presumably representing the combined expression of CYPlAl and 1A2. In contrast, CYPlA2 can be detected in livers only at -1 day of age and older, and then in only a very limited number of hepatocytes scattered throughout the lobule. Northem blot analysis of the mRNA from neonatal (1-28-day-old) rabbit livers showed that minor amounts of CYPlAl mRNA could be detected at all ages, with substantial increases occurring from 21 days onward (40) . In contrast, this group did not detect CYPlA2 mRNA in newborns, expression being found in rabbits only from 8-12 days old and above. The immunoblot data presented here parallel the above-reported developmental pattern for constitutive levels of mRNA. However, by using immunocytochemical analysis, expression of CYPlA2 is detected earlier in a limited number of hepatocytes. Such low levels of expression on a per mg liver protein basis may be below the limits of detection for Northern blotting.
After birth, the content of CYPIA2 increases as a percentage of the total hepatic P450 content until after weaning, as also observed by Bonfiis et al. (19) . However, whereas Bonfii and co-workers reported that CYPIA2 accounted for 33-4596 of total P450 content in rabbits of a 4 weeks of age (weanling), in the present study CYPlA2 accounted for only 615% of total P450. The reason for this difference is not known but may be due to the nature of the antibody and/or the technique used in immunoquantification. There is a dramatic surge of the levels of CYPIA2 between 6 and 11 days, which is associated with a progressive increase in the number of hepatocytes expressing CYP1A2, an increasingly wide zone around the central vein staining positively until weaning, when all of the cells throughout the lobule are positive. Recently, it has been shown that in human CYPIA2 is undetectable until some time after birth and, unlike that in the rabbit, maintains a centrilobular distribution through to adulthood (41) .
The difference in distribution of CYPlAl and 1A2 and the on-togenetic changes in the expression of the latter enzyme may reflect alterations in factors such as nutrient supply and hormone levels, which vary markedly during development with different patterns in different species (42, 43) . There is increasing evidence for the importance of diet to P450 expression during development. The levels of both CYPlAl and 1A2 change markedly around the time of weaning in the rabbit (7), as do those of a number of other P450 enzymes (19) . Although it was not possible in these studies to establish the stimulus for such changes in P450 expression, recently Pineau et al. (20) have shown that there is a causal relationship between the change in diet at weaning and increased expression of CYPlAl and 1A2. Artificially scheduled weaning, either early or delayed, results in a corresponding alteration in the time at which increased expression of these enzymes becomes apparent. Steroid hormones, such as glucocorticoids, are known to modulate the expression of a number of P450 genes. For example, dexamethasone interacts with specific regions within the first intron of the CYPlAl gene to increase the content of the respective mRNA in fetal rat hepatocytes in primary culture (44) . Whether this also occurs in vivo remains to be determined. Unidentified maternal factors have also been shown to affect total P450 specific content and the activities of aryl hydrocarbon hydroxylase (AHH) and acetanilide 4-hydroxylase, characteristic of members of the CYPlA subfamily (45) . These maternal factors are without effect on the development of testosteIone 15a-and 16a-hydroxylase and NADPHcytochrome c reductase activities, demonstrating the specificity of the effect.
Transplacental treatment of rabbits with polycyclic aromatic hydrocarbons, such as MC, is known to increase the hepatic P450 content of fetal and neonatal animals (7. 26) and was confirmed in the present study. There is now good evidence that the inducibility of CYPlAl and 1A2 is subject to differential ontogenetic regulation in several species, including rabbit, rat, and mouse, at both the mRNA and the protein level (5,7,8, 26, 40, 46, 47) . This was also found in the present study in the rabbit, the inducibility of CYPlAl being apparent, by immunoblotting, at the earliest age investigated, -4 days, whereas the inducibility of CYPlA2 as assessed by this technique was not manifest until about 6 days of age. The induction of CYPlAl appears to dedine around the perinatal period and then increases over the first 2 weeks of life, reaching a maximum at 9-11 days of age, as seen for AHH activity in an earlier study (7) . The inducibility of CYPlA2 shows a dramatic increase at this age, reaching a maximum of 1050 pmol/mg protein (60% of total P450 content) at 17-21 days and then declining somewhat in older animals to 524 pmollmg protein (35% of total P450 content) in adults, although the maximal fold-inducibility, 80-fold, was at 9-11 days. These results substantiate previous findings from Atlas and co-workers (7), who showed similar changes to proteins of Mr 57,000 and 54,000 on polyacrylamide gels, corresponding to CYPlAl and 1A2, respectively, after treatment of rabbits with MC. These authors also found a slight decline in the inducibility of the band at 54,000 around the perinatal period. The induction of the lower M, protein was shown to parallel increases in N-acetylarylamine N-hydroxylase activity in the rabbit and in acetanilide 4-hydroxylase activity in the rat (8), activities now known to be selectively catalyzed by CYP1A2.
Immunoblotting of hepatic microsomal proteins provides an estimate of the average amount of the P450 enzymes present in all of the cells from which the microsomal fraction is isolated. Immunocytochemistry has the advantage of indicating the level of ~4 5 0 expression within individual cells and allows a critical assessment of the intercellular variability. With this technique it has been possible to demonstrate, for the first time, that the apparent lack of induction of CYPlA2 in rabbit fetal and neonatal liver is not confined to all cells. A few scattered hepatocytes do exhibit increased expression after transplacental treatment with MC, from at least 4 days before birth. Induction of CYPIA2 appears to occur both in hepatocytes expressing moderate levels of the enzyme constitutively, particularly around the central vein, and in cells where the constitutive expression of CYPlA2 is low or even absent. Clearly, the fold-induction in the latter cells is greater than in cells that are constitutively active. Therefore, after MC treatment the liver appears to be developmentally advanced, by approximately 10-20 days, with respect to both the specific content of ~4 5 0 and the distribution of CYP1A2. This has important implications for pharmacological and toxicological studies, particularly of compounds activated by CYP1A2, in the developing rabbit. Transplacental induction by MC, but not by phenobarbital, markedly increases the incidence of fetal malformations caused by 2-acetylaminofluorene, a substrate of CYPlA, in the rat (48) .
The even distribution of CYPlAl throughout the lobule contrasts markedly with that of CYPIA2 and does not change after treatment of rabbits with MC, there being no evidence for any zonal selectivity of induction at any age. The homogeneous distribution of CYPlAl in the developing rabbit liver after MC treatment is consistent with the distribution reported for CYPlAl mRNA in the developing mouse liver, from 12.5 days of gestation after MC treatment, as determined by in situ hybridization (49) . Developmentally, inducibility of CYPlAl mRNA in the mouse is reported to occur at least 2 weeks earlier in gestation than that of CYPlA2, which occurs near the time of birth ( 5 ) . In the rabbit, whereas inducibility of CYPlAl mRNA occurred at all ages studied (1-28 days), inducibility of CYPlA2 mRNA was not apparent until 3 days after birth (40) . In general, our findings are consistent with these data, with the exception that we detected inducibility of CYPlA2 (in some cells only) a few days earlier. This discrepancy is probably a result of the differences in the sensitivities of the techniques employed.
The factors controlling the inducibility of CYPlAl and 1A2 have yet to be determined. Both genes possess upstream regulatory elements that can be activated by polycyclic aromatic hydrocarbons via the Ah receptor. Additional factors determine tissue and developmental regulation. These may act either preor posttranscriptionally, or both. It is not yet clear whether similar factors are responsible for determining tissue-specific and development-specific regulation. We have demonstrated for the first time that individual hepatocytes are subject to differential regulation during development for both constitutive and inducible activity. There is evidence that different factors are involved in these two phenomena. An intriguing question is whether the constitutive expression of CYPIA2 in a few hepatocytes in the fetal liver is specific for this enzyme or whether these cells are more generally developmentally advanced.
